Trial intelligence / Profile preview

Etanercept vs Methotrexate in Japanese RA

NCT00445770Phase 3Completed

Sponsor
Pfizer
Start
Jul 2006
Primary completion
Jul 2010
Modality
Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 3 trial of etanercept in rheumatoid arthritis (RA), sponsored by Pfizer. Started Jul 2006; status: completed.

02

Drugs

etanercept
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT00445770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00445770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call